Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens - PubMed
Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens
F T Rapaport et al. J Clin Invest. 1968 Oct.
Abstract
Erythrocyte group antigens A and B can act as potent and group-specific transplantation antigens in man. ABO group-incompatible recipients pretreated with such antigens have rejected skin allografts obtained from donors incompatible for the same antigens in an accelerated (4-5 days) or white graft manner. Skin grafts applied to the same recipients from ABO-compatible donors were accorded first-set survival times. Intact erythrocyte suspensions and antigens isolated from hog (A substance) and horse (B substance) stomachs, were equally capable of inducing this type of allograft sensitivity. The latter observation broadens the spectrum of heterologous antigens capable of inducing allograft sensitivity in the mammalian host and provides a readily available, heat-stable, and water-soluble source of antigens for further studies of allograft rejection mechanisms in man.
Similar articles
-
Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U. Galili U. Transfus Apher Sci. 2006 Aug;35(1):45-58. doi: 10.1016/j.transci.2006.05.007. Epub 2006 Aug 14. Transfus Apher Sci. 2006. PMID: 16905361 Review.
-
Nordén G, Briggs D, Cockwell P, Lipkin G, Mjörnstedt L, Mölne J, Ready A, Rydberg L, Samuelsson O, Svalander CT, Breimer ME. Nordén G, et al. Xenotransplantation. 2006 Mar;13(2):148-53. doi: 10.1111/j.1399-3089.2006.00280.x. Xenotransplantation. 2006. PMID: 16623810
-
Colombani J, Dausset J. Colombani J, et al. Pathol Biol (Paris). 1969 Mar;17(5):281-99. Pathol Biol (Paris). 1969. PMID: 4239837 Review. French. No abstract available.
-
Tanabe T, Ishida H, Horita S, Yamaguchi Y, Toma H, Tanabe K. Tanabe T, et al. Transpl Immunol. 2011 Jul;25(1):1-6. doi: 10.1016/j.trim.2011.05.002. Epub 2011 May 17. Transpl Immunol. 2011. PMID: 21616149 Clinical Trial.
Cited by
-
The biological basis of and strategies for clinical xenotransplantation.
Starzl TE, Valdivia LA, Murase N, Demetris AJ, Fontes P, Rao AS, Manez R, Marino IR, Todo S, Thomson AW, et al. Starzl TE, et al. Immunol Rev. 1994 Oct;141:213-44. doi: 10.1111/j.1600-065x.1994.tb00879.x. Immunol Rev. 1994. PMID: 7868154 Free PMC article. Review.
-
Boehmig HJ, Giles GR, Amemiya H, Wilson CB, Coburg AJ, Genton E, Bunch DL, Dixon FJ, Starzl TE. Boehmig HJ, et al. Transplant Proc. 1971 Jun;3(2):1105-17. Transplant Proc. 1971. PMID: 4944050 Free PMC article. No abstract available.
-
Stickel DL, Seigler HF, Amos DB, Ward FE, Gunnells JC Jr, Price AR, Anderson EE. Stickel DL, et al. Ann Surg. 1970 Aug;172(2):160-79. doi: 10.1097/00000658-197008000-00002. Ann Surg. 1970. PMID: 4914816 Free PMC article. No abstract available.
-
The definition of ABO factors in transplantation: relation to other humoral antibody states.
Starzl TE, Tzakis A, Makowka L, Banner B, Demetrius A, Ramsey G, Duquesnoy R, Griffin M. Starzl TE, et al. Transplant Proc. 1987 Dec;19(6):4492-7. Transplant Proc. 1987. PMID: 3321606 Free PMC article. Review.
-
History of clinical transplantation.
Starzl TE. Starzl TE. World J Surg. 2000 Jul;24(7):759-82. doi: 10.1007/s002680010124. World J Surg. 2000. PMID: 10833242 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources